Animal immune cells are widely used to connect mechanistic immunology with preclinical and translational research. The challenge is rarely simply obtaining “immune cells.” Researchers need the right biological source, species or strain, cell composition, post-thaw quality, and product format for the question being asked. A PBMC preparation, a bone marrow mononuclear cell preparation, and a splenocyte preparation can each provide a different view of the immune system and should not be treated as interchangeable materials.
For teams planning immune profiling, ex vivo stimulation, cell-mediated cytotoxicity, cytokine-response studies, or cross-species comparisons, selection should therefore begin with the experimental endpoint and work backward to the appropriate animal model and immune-cell source. This guide explains the main animal immune-cell formats, the factors that matter during selection, and the brochure-supported product and characterization information available from MileCell. Numerical product-performance statements and flow-cytometry values are taken from the supplied MileCell animal primary-cell brochure.
What Are Animal Immune Cells?
Animal immune cells are primary leukocyte-containing preparations isolated from biologically relevant tissues such as peripheral blood, bone marrow, or spleen. Unlike immortalized cell lines, primary immune-cell preparations preserve the mixed cellular populations and donor- or species-specific biology that researchers often need when evaluating immune phenotype and function.
The MileCell animal immune-cell portfolio includes peripheral blood mononuclear cells (PBMCs), bone marrow mononuclear cells (BMMCs), splenocytes, and splenic lymphocytes. The supplied brochure presents these products for immunology-focused in vitro studies, immune profiling, functional assays, and translational research across a broad range of animal species.
| Selection principle：Choose the immune-cell source according to the biological question first, then confirm species or strain, expected immune composition, post-thaw quality, pack size, and the characterization data available for the selected lot or product family. |
Which Animal Immune Cell Types Are Commonly Used?
1. Peripheral Blood Mononuclear Cells (PBMCs)
PBMCs contain circulating mononuclear leukocytes and are among the most practical primary-cell formats for immune profiling and functional testing. Because they are collected from peripheral blood, they are especially useful when the study requires access to circulating T cells, B cells, monocytes, and related leukocyte populations without the tissue complexity of spleen or bone marrow.
In the MileCell brochure, PBMC products are listed for C57BL/6N, BALB/c, and CD-1 mice; SD, Wistar Han, and Lewis rats; cynomolgus and rhesus monkeys; Beagle dog; Bama minipig and Landrace pig; New Zealand rabbit; domestic cat; and alpaca. The listed PBMC products are supplied at 10 million cells per vial.
2. Bone Marrow Mononuclear Cells (BMMCs)
BMMCs provide a broader view of the hematopoietic compartment than peripheral blood. They can be useful when the study is focused on bone-marrow-resident mononuclear populations, immune-cell development, hematopoietic responses, or assays in which the marrow compartment is biologically relevant. The supplied MileCell portfolio lists cynomolgus monkey and rhesus monkey BMMCs, each at 10 million cells.
3. Splenocytes and Splenic Lymphocytes
The spleen is a major secondary lymphoid organ, and splenocyte preparations provide access to a tissue-resident mixture of immune cells that differs from circulating PBMCs. Splenic lymphocyte preparations offer a more lymphocyte-focused material when that narrower composition better matches the experimental endpoint. MileCell lists splenocytes and splenic lymphocytes from mouse, rat, monkey, and Beagle dog, with 10 million cells per listed product.
Why Species, Cell Source, and Immune Composition Matter
Preclinical immunology studies often need to balance biological relevance with experimental continuity. Species, strain, breed, tissue source, and immune composition can all affect the interpretation of an assay. For example, a circulating PBMC model may be appropriate for comparing peripheral immune responses, while splenocytes may be preferred when a lymphoid-organ context is more relevant. Non-human primate cells can provide another translational layer when the research program requires an immune system more closely aligned with the intended preclinical model.
The key is not to assume that one cell source can answer every immunology question. Instead, define the population and function to be measured, then select the cell source and species that make the assay interpretable. When a particular immune subset is central to the study, enrichment or custom isolation can further reduce biological ambiguity.
Key Features to Consider When Selecting Animal Immune Cells
1. Post-Thaw Quality
Cryopreserved primary immune cells must recover sufficiently after thawing to support the intended assay. The MileCell brochure lists high post-thaw viability as a product feature for animal immune cells, but it does not provide one universal numerical viability specification for the entire immune-cell portfolio. Lot-specific or product-specific quality information should therefore be reviewed when available.
2. Immune Subpopulation Composition
For mixed primary-cell products such as PBMCs, viability alone is not enough. The relative representation of leukocytes, T cells, B cells, monocytes, and T-cell subsets can directly affect downstream readouts. Flow-cytometric characterization is therefore an important way to confirm whether the preparation has a biologically useful composition.
3. Species and Strain Coverage
A broad species portfolio is useful when the same immune endpoint must be evaluated across discovery and preclinical models. MileCell lists mouse, rat, non-human primate, canine, porcine, feline, rabbit, and alpaca PBMC options, with additional splenocyte and BMMC offerings in selected species.
4. Fit-for-Purpose Cell Source
PBMCs, BMMCs, splenocytes, and splenic lymphocytes represent different biological compartments. The preferred material should be determined by the tissue context and immune function relevant to the assay, rather than by availability alone.
5. Supply and Batch Planning
The brochure highlights well-stocked inventory and customizable pack size and batch size. For studies that span multiple plates, time points, or sites, planning around a suitable batch can reduce avoidable variability and simplify study execution.
6. Custom Immune-Subset Isolation
When a study requires a defined immune population rather than a mixed mononuclear-cell preparation, the brochure states that custom isolation is available for immune subtypes such as CD3, CD4, CD8, CD14, CD19, and CD56 according to project specifications.
Quick Reference: Evaluating Animal Immune Cells
| Evaluation Area | Key Question | Brochure-Supported Information |
|---|---|---|
| Cell source | Does the tissue source match the biology being studied? | PBMCs, BMMCs, splenocytes, and splenic lymphocytes are listed. |
| Species selection | Is the required animal model available? | PBMC coverage includes mouse, rat, NHP, dog, pig/minipig, rabbit, feline, and alpaca. |
| Post-thaw quality | Is recovery suitable for the downstream assay? | High post-thaw viability is listed as a product feature; no universal numerical threshold is provided for the entire immune-cell portfolio. |
| Immune composition | Is the relevant subset represented and characterized? | Rhesus Monkey PBMC flow data include CD45, CD3, CD4, CD8, CD20, and CD14 populations. |
| Product size | Is the cell number appropriate for the assay? | The listed PBMC, BMMC, splenocyte, and splenic-lymphocyte products are 10 million cells. |
| Customization | Can the material be aligned with the project? | Gender, species, pack size, batch size, and custom immune-subset isolation can be discussed according to the brochure. |
Experimental Data from the Product Brochure
Flow-Cytometric Characterization of Rhesus Monkey PBMCs
The MileCell brochure provides a flow-cytometry example for Rhesus Monkey PBMCs (lot RM25S011C). The analysis shows a high proportion of CD45-positive leukocytes and characterizes major lymphoid and myeloid populations. This type of profile is useful because it allows researchers to evaluate whether the recovered preparation contains the expected immune-cell compartments before investing in more complex functional assays.
Figure 1. Flow-cytometric characterization of Rhesus Monkey PBMCs (lot RM25S011C). Brochure-reported values include CD45+ 98.35%, CD3+ 66.09%, CD20+ 25.83%, and CD14+ 4.03%. Within the CD3+ gate, CD4+CD8− cells are 64.97%, CD4−CD8+ cells are 30.00%, CD4+CD8+ cells are 2.89%, and CD4−CD8− cells are 2.14%. The figure background has been converted to white without altering the plotted data or labels.
| Readout | Brochure value | Interpretive role | |
|---|---|---|---|
| CD45+ | 98.35% | Confirms a predominantly leukocyte population in the analyzed gate. | |
| CD3+ | 66.09% | Represents the T-cell compartment in the displayed analysis. | |
| CD20+ | 25.83% | Represents the B-cell compartment in the displayed analysis. | |
| CD14+ | 4.03% | Represents the monocyte population in the displayed analysis. | |
| CD4+CD8− within CD3+ | 64.97% | Helper-T-cell–dominant subset in the displayed CD3+ gate. | |
| CD4−CD8+ within CD3+ | 30.00% | Cytotoxic-T-cell subset in the displayed CD3+ gate. | |
| Data interpretation: The plotted values characterize the specific Rhesus Monkey PBMC example shown in the brochure. They should not be treated as universal specifications for every rhesus PBMC lot or for PBMCs from other species. |
Practical Considerations for Product Selection
A practical selection workflow starts with the assay and then narrows the product choice. Before ordering animal immune cells, researchers should confirm the following fields with the supplier or lot documentation:
· Species, strain, or breed required by the preclinical model.
· Biological source: peripheral blood, bone marrow, spleen, or a defined immune subset.
· Required cell number and pack size for the planned assay format.
· Post-thaw viability and any lot-specific quality-control information available.
· Immune-subpopulation characterization relevant to the planned endpoint.
· Whether a single lot or larger batch is preferred for multi-stage studies.
· Need for custom isolation of CD3/CD4/CD8 T cells, CD14 monocytes, CD19 B cells, CD56-positive cells, or other defined subsets.
Species and Cell-Type Coverage in the MileCell Portfolio
| Species / group | PBMCs | BMMCs | Splenocytes / splenic lymphocytes |
|---|---|---|---|
| Mouse | C57BL/6N, BALB/c, CD-1 | — | C57BL/6N, BALB/c, CD-1 |
| Rat | SD, Wistar Han, Lewis | — | SD, Wistar Han |
| Non-human primate | Cynomolgus, Rhesus | Cynomolgus, Rhesus | Cynomolgus, Rhesus |
| Dog | Beagle | — | Beagle |
| Porcine | Bama minipig, Landrace pig | — | — |
| Rabbit | New Zealand | — | — |
| Feline | Felis catus | — | — |
| Alpaca | Alpaca | — | — |
Table 1. Species and cell types listed in the supplied MileCell animal immune-cell brochure. All listed immune-cell portfolio entries shown in the brochure are supplied at 10 million cells.
MileCell Animal Immune Cells
For research programs that need to move between rodent, non-human primate, canine, porcine, and other animal models, sourcing immune cells from a consistent portfolio can simplify study planning. MileCell provides cryopreserved PBMCs, BMMCs, splenocytes, and splenic lymphocytes across multiple species, supported by quality-control testing and flow-cytometric characterization where shown in the product brochure.
The value for researchers is flexibility rather than a one-size-fits-all product: species, gender, pack size, and batch size can be discussed according to study needs, and custom isolation is available for defined immune subsets such as CD3/CD4/CD8, CD14, CD19, and CD56. This makes the portfolio suitable for teams that need either mixed mononuclear-cell preparations or more targeted immune-cell inputs for downstream assays.
| Next step: Explore MileCell Animal Immune Cells, request current lot information and available characterization data, download the animal primary-cell brochure, or contact the MileCell team to discuss species, cell source, batch size, and custom immune-subset requirements. |
FAQ: Animal Immune Cells
What are animal immune cells used for?
Animal immune cells are used in immunology-focused in vitro studies including immune profiling, functional assays, cross-species comparisons, and translational research. The appropriate application depends on the selected species, tissue source, and immune-cell composition.
What is the difference between PBMCs and splenocytes?
PBMCs are isolated from peripheral blood and primarily represent circulating mononuclear leukocytes. Splenocytes are isolated from spleen and represent a lymphoid-organ cell mixture. The better choice depends on whether the assay is intended to model circulating or spleen-associated immune biology.
Which animal PBMC species are available from MileCell?
The supplied brochure lists PBMCs from mouse, rat, cynomolgus monkey, rhesus monkey, Beagle dog, Bama minipig, Landrace pig, New Zealand rabbit, domestic cat, and alpaca.
What size are the listed animal immune-cell products?
The PBMC, BMMC, splenocyte, and splenic-lymphocyte entries shown in the supplied brochure are listed at 10 million cells.
Does MileCell provide immune-subset characterization?
The brochure includes flow-cytometric characterization of Rhesus Monkey PBMCs and reports CD45, CD3, CD4, CD8, CD20, and CD14 populations for the example shown.
Can defined immune subsets be isolated?
Yes. The brochure states that custom cell-isolation services are available for immune subtypes such as CD3, CD4, CD8, CD14, CD19, and CD56 according to project specifications.
Conclusion
Animal immune-cell selection is most effective when the assay endpoint drives the choice of species, tissue source, and immune composition. PBMCs provide a practical window into circulating mononuclear leukocytes, BMMCs address the bone-marrow compartment, and splenocytes or splenic lymphocytes offer access to spleen-derived immune populations. Across all of these formats, post-thaw quality, population composition, batch planning, and lot-specific characterization matter for reproducible downstream work.
For researchers evaluating animal immune cells, the MileCell brochure provides a broad multi-species portfolio, 10-million-cell product formats for the listed immune-cell entries, configurable project options, custom immune-subset isolation, and a detailed Rhesus Monkey PBMC flow-cytometry example. Product selection should still be matched to the exact experimental design and the documentation available for the chosen lot.
Looking for animal immune cells for immunology or translational research? Explore MileCell PBMCs, BMMCs, splenocytes, and custom immune-cell isolation options, request current lot information and characterization data, or contact the MileCell team for technical support.
Contact: Info@milecell-bio.com | Website: www.milecell-bio.com
